EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of Chlamydia trachomatis burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment

Caleb M Ardizzone, Christopher M Taylor, Evelyn Toh, Rebecca A Lillis, Jacob H Elnaggar, John W Lammons, Patricia Dehon Mott, Emily L Duffy, Li Shen, Alison J Quayle

Frontiers in Cellular and Infection Microbiology · 12.12.2023 · 13

DOI: 10.3389/fcimb.2023.1289449 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 12.12.2023. Verfasst von Caleb M Ardizzone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States. Hauptthemen laut MEDLINE: Vaginosis, Bacterial, Microbiota. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial vaginosis (BV), a dysbiosis of the vaginal microbiota, is a common coinfection with Chlamydia trachomatis (Ct), and BV-associated bacteria (BVAB) and their products have been implicated in aiding Ct evade natural immunity. Here, we determined if a non-optimal vaginal microbiota was associated with a higher genital Ct burden and if metronidazole, a standard treatment for BV, would reduce Ct burden or aid in natural clearance of Ct infection. Cervicovaginal samples were collected from women at enrollment and, if testing positive for Ct infection, at a follow-up visit approximately one week later. Cervical Ct burden was assessed by inclusion forming units (IFU) and Ct genome copy number (GCN), and 16S rRNA gene sequencing was used to determine the composition of the vaginal microbiota. We observed a six-log spectrum of IFU and an eight-log spectrum of GCN in our study participants at their enrollment visit, but BV, as indicated by Amsel’s criteria, Nugent scoring, or VALENCIA community state typing, did not predict infectious and total Ct burden, although IFU : GCN increased with Amsel and Nugent scores and in BV-like community state types. Ct burden was, however, associated with the abundance of bacterial species in the vaginal microbiota, negatively with Lactobacillus crispatus and positively with Prevotella bivia . Women diagnosed with BV were treated with metronidazole, and Ct burden was significantly reduced in those who resolved BV with treatment. A subset of women naturally cleared Ct infection in the interim, typified by low Ct burden at enrollment and resolution of BV. Abundance of many BVAB decreased, and Lactobacillus increased, in response to metronidazole treatment, but no changes in abundances of specific vaginal bacteria were unique to women who spontaneously cleared Ct infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaginosis, BacterialMicrobiotaFemaleHumansMetronidazoleChlamydia trachomatisRNA, Ribosomal, 16SVagina

Stichwörter der Autor:innen

Chlamydia trachomatisLactobacillusPrevotellabacterial vaginosismetronidazolenatural clearancevaginal microbiomewomen

Substanzen

MetronidazoleRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Department of Microbiology, Immunology, and Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Department of Medicine, Section of Infectious Diseases, Louisiana State University Health Sciences Center, New Orleans, LA, United States.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Ardizzone, C. M., Taylor, C. M., Toh, E., Lillis, R. A., Elnaggar, J. H., Lammons, J. W., Mott, P. D., Duffy, E. L., Shen, L., & Quayle, A. J. (2023). Association of Chlamydia trachomatis burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment. Frontiers in Cellular and Infection Microbiology, 13. https://doi.org/10.3389/fcimb.2023.1289449

Vancouver

Ardizzone CM, Taylor CM, Toh E, Lillis RA, Elnaggar JH, Lammons JW, et al. Association of Chlamydia trachomatis burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment. Frontiers in Cellular and Infection Microbiology. 2023;13. doi:10.3389/fcimb.2023.1289449

BibTeX
@article{Ardizzone2023,
  author = {Ardizzone, Caleb M and Taylor, Christopher M and Toh, Evelyn and Lillis, Rebecca A and Elnaggar, Jacob H and Lammons, John W and Mott, Patricia Dehon and Duffy, Emily L and Shen, Li and Quayle, Alison J},
  title = {Association of Chlamydia trachomatis burden with the vaginal microbiota, bacterial vaginosis, and metronidazole treatment},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fcimb.2023.1289449}
}
Kostenlos starten →